Introduction
Celiac disease (CD) is an immune-mediated chronic enteropathy, produced by the interaction of certain haplotypes (genes) of the host that provide the genetic susceptibility 1 and the environment, which contributes the prolamins of gluten in the diet 2 . Other factors, such as epigenetics and host microbiota, would participate in the pathogenesis of CD through less-known mechanisms 3 . It is currently recognized as a high-frequency autoimmune condition, which appears at any age 4 , reaching a global prevalence of 1-3% of the population 5 . It is diagnosed by serology (measurement of antibodies against tissue transglutaminase 2(TTG), anti-endomysial (EMA) antibodies or deamidated gliadin peptides (DGP) and histological confirmation in duodenal biopsies, which show various degrees of lymphocytic infiltration, crypt hyperplasia, and villous flattening 4, 6 . By now, the only effective treatment for CD is the gluten-free diet (GFD), strict, permanent and lifelong 4 . This diet eliminates wheat, rye, and barley from the diet, included in both natural and processed foods 7 . Oats are also usually eliminated because it has a high probability of being contaminated 8 . The main limitation of this treatment is the lack of adherence of patients to GFD.
The treatment of CD includes patients follow-up, periodic and long-term, to evaluate the clinical course and adherence to GFD. This evaluation is difficult because there is no reliable and reproducible method to measure the actual gluten intake. The current strategy is based on the consensus of specialists 4 . They recommend periodic check-ups that estimate the adherence based on what the patient reports and the measurement of antibodies that reflect autoimmunity. The most used are TTG 9, 10 . It is expected that, by not eating gluten, patients will show blood clearance and progressive reduction of the intestinal mucosa damage and autoimmunity phenomena. However, the usefulness of these antibodies for follow-up has currently under discussion [11] [12] [13] , exposing again the problem of how to ensure that the information provided by the patient is accurate and reliable. Foreign data show that adherence to GFD in children is 80-95% and in adolescents and adults 36-52% 14, 15 . Assessing adherence through interviews by specialized professionals and validated questionnaires is giving promising results, but not yet definitive ones 12, 16 . In Chile, studies indicate that pediatric patients who adhere to GFD vary between 24-34% 17-19 , without significant variations over time. The World Health Organization (WHO) has described five types of factors that influence the adherence to a chronic treatment: related to the disease, the patient, the treatment, the health system or health team, and the socioeconomic characteristics. The information about how these factors affect the celiac patient and the GFD is insufficient. Considering that the available data in our country are scarce, show low degrees of adherence and that in the national public health system the follow-up is by serology (TTG and occasionally EMA), the objective of this study was to evaluate the factors that influence in adherence to GFD. Additionally, the concordance between the measured antibodies (TTG and EMA) and the nutritional adherence questionnaire was evaluated.
Patients and Methods

Study group
Cross-sectional, analytical study that assessed the universe of patients diagnosed with CD treated at the Gastroenterology Service of the Roberto del Río Hospital (HRR), Santiago, 2008-2016. Patients under 18 years of age, diagnosed by serology and intestinal biopsy 4 and following GFD for at least six months before the study were included. The protocol was accepted by the Ethics Committee of the Institute of Nutrition and Food Technology (INTA), University of Chile, by the HRR Management, and the Ethics Committee of the North Metropolitan Health Service (SSMN). The records of consultations during the period were reviewed (code K90.0, diagnosis of CE in the international statistical classification of diseases and related health problems ICD10, WHO 2005). Out of 101 patients detected, 86 met inclusion criteria and were contacted by telephone to invite them to participate. However, 15 were not available and six did not show up for the interview (despite four telephone attempts). Although this represents a selection bias in the study group, the information on the clinical records showed that demographic and biological characteristics of these 15 and six mentioned patients did not show significant differences from patients included in the analysis. After explaining the protocol and obtaining informed consent, 65 patients entered the study. The participants (patients and/or parents or guardians) answered an ad hoc questionnaire that addressed the five groups of factors indicated by the WHO 20 .
The following were recorded: General data: sociodemographic characteristics and socioeconomic level (according to Esomar survey, Adimark, October 2000). History: weight, height, and physical examination. The clinical characteristics were registered at the time of diagnosis and during the last three months, including date and age of diagnosis, gastrointestinal symptoms (diarrhea, abdominal distension, anorexia, constipation, steatorrhea, malnutrition, abdominal pain, vomiting, celiac crisis), extra gastrointestinal symptoms (anemia, short stature, pubertal delay, dental enamel hypoplasia); and the presence of associated autoimmune diseases (diabetes mellitus type I, autoimmune thyroiditis, autoimmune hepatitis, dermatitis herpetiformis). Patients were classified as typical, atypical or silent. The anthropometry followed the current Chilean criteria (Ministry of Health of Chile) 21 , corrected by Tanner 22 as needed. Disease Management: During the last three months, the diet was recorded, including the perception (of parents/guardians and the patient if adolescent) of following GFD correctly; knowledge of the allowed foods and the availability of those in the country, knowledge of the gluten-free symbols and if the patient does or does not read the food ingredients list before buying it. A knowledge score was made, giving a point to each correct answer (minimum 0 and maximum 4). In addition, we asked: i) if they knew support groups for celiac patients and if they attended their meetings or visited their websites; ii) if the school was aware of the patient's condition, whether or not the patient had received support from the school and if the school allowed the patient to bring his/her own food or if he/she had to consume the food provided by the school; iii) if the patient does or does not break the regime when eating out of home, the behavior in birthdays or social events out of home, if inthi¿ese occasion the patient chooses only gluten-free foods, consumes anything, brings food from home or does not participate in this kind of events; iv) patient's behavior in case of need for treatments with oral medications, and for the intake of food (wine, wafer, bread, matzo) in religious ceremonies; v) access to an evaluation and/or check-up with nutritionist, psychologist and/or social worker. A subgroup (patients entered to the study after 2009) also answered the adherence questionnaire to the gluten-free diet described by Biagi 16 .
Procedures
EMA and TTG were measured within two weeks after the interview. The measurement of serum IgA ruled out IgA deficiency in all participants. It was not possible to measure TTG in four patients and EMA in nine. In both cases, patients did not attend sample collection. The anthropometric evaluation (weight and height) was performed with a Seca digital scale. The Biagi questionnaire was applied following author's instructions. It is based on four questions that inform about if the patient eats gluten voluntarily, the behavior they have when eating outside, reading the labeling of packaged foods looking for if they contain gluten and if only eats foods guaranteed by some Association of celiac patients 16 .
Analysis of results
Descriptive statistics were applied; the analysis was carried out in two ways: a) accepting that adherence is represented by the negative results of the serological markers (TTG antibodies and negative EMA) and b) by the data obtained by the nutritional questionnaire (Biagi) . The concordance between the TTG and the nutritional adherence questionnaire was analyzed with Kappa index; the association between the evaluated factors and the results of EMA and TTG (both negative), with chi-square test; Odd Ratio was used as a measure of association (95% confidence interval). Logistic regression was applied to the factors associated with the results of EMA and TTG (positive-negative). "Good adherence to GFD" was defined when EMA and TTG were both negative.
Results
The universe of patients (2008-2016) with diagnosis of CD was 101, which represents 0.04% of the new consultations made at the HRR during the period 23 . 86/101 patients met the inclusion criteria and 65 (75.6%) agreed to enter the study. 61.5% were girls, a percentage higher than in the general population in that age group 24 . 69.2% of patients were eutrophic, 10.8% at risk or malnourished, and 20% were overweight or obese. In the assessed age group, the percentage of eutrophic/at nutritional risk was higher and the percentage of obesity was lower than in the general population 25 . 86% of the patients lived in the Metropolitan Region, 93.8% was using Fonasa (public health system) as health system and 86% was in middle socioeconomic level (SEL), according to Esomar 2000 classification. 50.8% of the patients were preschool children or had completed 4th grade or less. 66.1% of mothers and 55.4% of fathers had completed secondary education or higher. Table 1 shows the variables related to the patient and his/her disease and table 2 the knowledge, disease management, and lifestyle. 52.3% of the interviewed patients (or guardians) stated that the GFD was handled correctly. There was 100% of concordance between the responses of adolescents and their parents or guardians. 43.1% (28 patients) received at least one medication permanently, mainly levothyroxine, insulin, zinc sulfate, polyvitamins, ferrous sulfate, folic acid, and valproic acid. 6.2% reported receiving food in religious ceremonies, 10.8% did not commune due to fear of getting sick, and 43% had doubts about their first communion.
Graph 1 shows the frequency of adherence/transgression to the GFD measured by the presence of antibodies EMA +/-, TTG +/-, EMA and TTG +/-, and EMA or TTG +/-. According to the adherence questionnaire to the GFD (scores 3 and 4 of Biagi), 30.8% adhered strictly to the GFD. There was concordance between the questionnaire and both tests performed both antibodies. Among patients whose guardian thinks that they are making mistakes in the GFD, 75.9% had some positive serology, but 24.1% of the patients, although they stated to transgress the regimen, maintained both blood antibodies negative. The third significant variable was the "habits that patients have at birthdays and/or social events" (p = 0.005). Those who choose only gluten-free foods or those who take food from their homes had a significantly higher frequency of negative TTG and EMA (adherence) than those who do not follow the diet on social occasions. 63.2% of those who choose "only gluten-free" and 57.1% of those who take food from home, had negative serology. 8/9 (88.9%) patients who "eat everything" had some positive test (EMA or TTG). Meanwhile, 90% of patients who do not attend birthdays had positive serology (EMA or TTG). In relation to EMA, there were two significant variables: "read and their combinations, being all P significant with moderate concordance force (table 3) . In the analysis of adherence defined by serology (chi-square), only three variables were significant: "age of disease onset" (p = 0.049), "perception of doing well the GFD" (p = 0.002) and "behavior of the patient in front of food in social events"(p = 0.005). Assessed by serology at the time of the interview, those diagnosed before two years of age, between 2-10 years and after 10 years old, 60.7%, 28% and 33.3% were adherent to the GFD, respectively. At the time of the interview, 63.3% of those who "think that they are correctly following GFD" had negative ingredients in the nutrition labeling" (p = 0.041) and "feel welcomed by the foundations supporting the celiac patient" (p = 0.045), but these variables were not significant for the combination EMA-TTG. The selfperception analysis of the GFD and the Biagi questionnaire showed 72% of concordance. 10/11 patients in whom there was no concordance thought they were doing well with the diet and the Biagi questionnaire classified them as transgressors.
The logistic regression provided a predictive model that included three variables: "perception of following well the GFD" (p = 0.003), "patient's behavior in front of foods in social events" (p = 0.003) and "age of disease onset" (p = 0.049). In the logistic regression model only two out of the three variables reached statistical significance (table 4) .
The GFD Knowledge Score did not show significant differences for adherence by serology. When dividing patients into those with a score of ≤ 3 and those with a score of 4 in the Biagi questionnaire, half of the patients were grouped in each group. Patients with Score ≤ 3 had 1.5 times more risk of transgressing the diet. Although this variable was not significant in the chi-square analysis, due to the importance of patient education, it was included in the multivariable logistic regression analysis.
Discussion
The adherence to GFD in this study is lower than the one published in the international literature for this age group 14, 19 , but similar to the ones described in our country in previous studies [17] [18] [19] , both by measurement of TTG and EMA antibodies and the questionnaire developed by Biagi. This indicates that the adherence to GFD among our pediatric patients is not only low but has not changed significantly in the last two decades. It is interesting that both methodologies showed concordance since other studies have not shown it 11 . The variable "perception" of following the GFD correctly, was the one that showed the best association with negative markers, being always statistically significant. The patient who believes that he/she is not doing a correct diet has 3.4 times higher risk of not adhering than the patient that believes that he/she follows GFD correctly The second t variable best associated with adherence was age of diagnosis. Patients diagnosed before two years of age showed significantly higher adherence to GFD than those diagnosed at later ages. One can think that the earlier CD is diagnosed, the easier it is to incorporate and accept the limitations imposed by GFD 8 . The "attitude in birthdays" was significant when making a univariate analysis, but it lost significance in the logistic regression of association, except in the group that "does not attend birthdays", which showed a greater risk of "transgressing the GFD". This implies that not taking celiac children to birthday parties does not protect them from transgressions to diet. That 90% of patients who did not attend a birthday presented positive serology (EMA or TTG) is against the expected; it could be interpreted as a behavioral option to avoid the opportunity to transgress 26 .
The guardian and/or the patient's "perception" of "being doing GFD properly" shows that two out of three patients who believe that they are following the diet, are really achieving it. This contrasts with the variables referring to knowledge itself about diet and gluten-free foods, which did not achieve statistical significance in any of the analyses. On the other hand, in patients whose guardian thinks that they make mistakes in GFD, 75.9% have some positive serology. It is interesting that 24.1% of patients (seven children), despite thinking that they are doing poorly, either because they eat gluten in an obvious way or because they do not have clear their indications of feeding, maintained negative both antibodies. This supports the idea that serology is not a good indicator for followup 11, [27] [28] [29] ; it also opens the possibility that some patients have certain tolerance to small amounts of gluten without arising a detectable autoimmune response 30 . Another possibility is that the time elapsed between the transgression of the diet and the measurement of markers was insufficient to produce a detectable change. Undoubtedly, it is necessary to improve the capacities to measure gluten intake in celiac patients along time. Measurements of gluten in stools and/or urine seem an interesting option, but the currently available results are not sufficient to propose them as marker of followup in t CD [31] [32] [33] [34] [35] .
In this respect, it is relevant to remind that if the-re are doubts about whether a patient has elevated antibodies because he/she does not adhere to GFD or because he/she does not respond to treatment, a new duodenal biopsy is useful, as well as a genetic study if it shows absence of risk haplotypes. Unfortunately, genetic studies are not usually practiced in our country. It is interesting that the patient or guardian that reads the nutritional labeling of packaged foods showed significant association with negative EMA. This relation with adherence could reflect a behavior of greater commitment to leading a good management of the disease. Results show that for health professionals to provide effective counseling to celiac patients, in addition to know the biological aspects of the disease, it is necessary they manage the emotional and social aspects imposed by chronic diseases. It must be considered that treatments that involve restrictions in daily life are difficult to maintain in the long-term and can affect quality of life 26, 36, 37 . This is important to highlight since we must recognize the enormous benefit that most patients who follow GFD have; they manage to stay asymptomatic and avoid the risks of long-term complications. In this sense, the chronic or sporadic consumption of medications and the intake of foods related to religious ceremonies gain interest. In the first case, it is important to choose gluten-free medicines and in case of not having safe alternatives, put in the balance the risk/benefit of each treatment. In the case of foods consumed in religious ceremonies, alternatives suitable for celiacs must be offered to maintain adherence to GFD, such as communion wafer for celiacs, as is the case in our country, where wafers are certified by the Archbishopric of Santiago. These aspects favor the integral recovery of the patient (physical, emotional and spiritual).
Due to the importance of patient education in the treatment of CD 38, 39 , the multivariable logistic regression analysis was adjusted by the knowledge score, although this was not significant in the univariate analysis. The fact that the "perception" of being doing correctly the GFD maintain its significance, seems to us a very relevant finding since it can be used to modify/reinforce behaviors and improve the follow-up and adherence to the treatment of celiac patients 4 .
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